Four classifiers (random forest, support-vector machine, logistic regression and multilayer perceptron) used six years of natural Arabidopsis leaf-microbiome data to prioritize taxa associated with Albugo infection status. Follow-up plant assays found that selected health-associated microbes reduced infection; Cystofilobasidium macerans OTU126 gave the strongest individual protection, reducing Albugo infection by an average of 73%. In a 15-member synthetic leaf community, adding this fungus increased the reported infection reduction to 40.25%, compared with 19.36% for the community alone.
Technology: Random forest, support-vector machine, logistic regression and multilayer perceptron classifiers with cross-validated feature selection
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Follow-up plant assays found that selected health-associated microbes reduced infection; Cystofilobasidium macerans OTU126 gave the strongest individual protection, reducing Albugo infection by an average of 73%.
- Still unknown: This is a controlled Arabidopsis–Albugo plant-pathogen model, not a field crop efficacy trial. ML features are associations with infection status; they do not establish the microbes caused naturally observed health status. Isolates were matched to predicted OTUs using marker sequences, which the authors note do not fully establish strain-level functional identity. Genomic terpene-cluster hypotheses were not directly tested. No commercial or field-ready biocontrol performance is established.
- AI role: Models classified infected versus uninfected plants from microbial community profiles and prioritized disease-associated and health-associated taxa for follow-up. Researchers then tested selected cultured isolates in planta and tested Cystofilobasidium in a synthetic community.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/42521687/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
A sequence-to-sequence transformer generated readable Python meta-programs that construct photonic experimental blueprints for entire families of quantum states, rather than only individual target states. In the final paper, two successful generalizations were previously unknown: a photonic construction for general spin-1/2 states with no adjacent spin-ups, and one for states of the Majumdar–Ghosh model. The generated programs matched states beyond the three examples used as input, providing computational evidence of the inferred rules.
Technology: Transformer-based sequence-to-sequence language model trained on synthetic quantum-state and experimental-blueprint pairs
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: A sequence-to-sequence transformer generated readable Python meta-programs that construct photonic experimental blueprints for entire families of quantum states, rather than only individual target states.
- Still unknown: This is a computational design result, not a laboratory realization of the proposed photonic experiments. Generalization was tested by checking generated states at finite larger sizes; the authors state that arbitrary code equivalence for all system sizes is not straightforward to prove. The two constructions are counted as one paper-level discovery.
- AI role: Generated human-readable Python meta-programs from short sequences of target quantum states; the model’s programs proposed reusable experimental construction rules for whole state families, which the authors checked by simulating output states at larger system sizes.
Evidence sources: https://www.nature.com/articles/s42256-025-01153-0
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
MolE-XGBoost prioritized existing compounds. Of six tested commercially available compounds, elvitegravir, opicapone and ebastine showed measured growth-inhibitory effects on S. aureus; visomitin was a known-antimicrobial positive control. Effects varied: elvitegravir inhibited growth at 8 μg/mL, while the other two limited or delayed growth. This is an in-vitro finding, not a clinical antibiotic.
Technology: MolE molecular representation learning; XGBoost
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: The primary source reports the study-specific result summarized here.
- Still unknown: Independent replication and broad deployment are not established by this review.
- AI role: A learned molecular representation and XGBoost rank candidates for experimental screening; selected compounds undergo MIC and growth-curve assays.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11986102/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: Primary-source indexed article or abstract and bibliographic metadata reviewed; complete source scope is given in source_checks..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.